MedTrace Logo

An E-health Letter Intervention for Caregivers

NCT05882461 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 330

Last updated 2023-05-31

No results posted yet for this study

Summary

The purpose of the present study is to conduct a two-arm Randomized Control Trial (RCT) comparing individuals receiving the 90Second Caregiver health letter, with a usual care (routine care received by caregivers) control group.

The goals of the present study are:

* To evaluate the effectiveness of the 90Second Caregiver health letter in improving caregiver's self-efficacy (primary outcome), savouring, and quality of life (secondary outcomes).
* To evaluate the effectiveness of the 90Second Caregiver health letter in reducing caregiver's psychological strain and caregiver burden (secondary outcomes).
* To examine the impact of levels of engagement with the 90Second Caregiver health letter on primary and secondary outcomes.
* To assess the usability of the 90Second Caregiver health letter, as it relates to the relevance of topic, user friendliness, and appropriateness of the readability levels.
* To evaluate psychometric properties of self-constructed measures in 90Second newsletter.

Conditions

  • Caregivers
  • Acquired Brain Injury

Interventions

BEHAVIORAL

90Second Caregiver health letter

Participant receives the weekly health letter via email

Sponsors & Collaborators

  • IWK Health Centre

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-17
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05882461 on ClinicalTrials.gov